RCM
CMRAW

Radcliffe Capital Management’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

Radcliffe Capital Management’s Portfolio CMRAW Stock Details CMRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40,000
Closed -$1.14K – 517
2023
Q2 		$1.14K Hold
40,000
– – ﹤0.01% 571
2023
Q1 		$2.01K Hold
40,000
– – ﹤0.01% 672
2022
Q4 		$49.2K Hold
40,000
– – ﹤0.01% 872
2022
Q3 		$64K Hold
40,000
– – ﹤0.01% 1184
2022
Q2 		$106K Buy
+40,000
New +$106K ﹤0.01% 1221